The purpose of this study is determine if the medication baclofen can prevent the symptoms of
Alcohol Withdrawal Syndrome (AWS) in hospitalized patients who may be at risk for AWS. This
medication is most often used for patients who have spasticity of their muscles due to a
neuromuscular disease. In several European studies, and in an earlier study at Essentia
Health (NCT00597701), baclofen has been found to have a significant effect on the severity of
symptoms of AWS.